Introduction Hypertrophic cardiomyopathy (HCM) is a complex cardiac disease with highly
variable phenotypic expression and clinical course most often caused by sarcomeric gene …

Background The impairment of endothelial cells triggered by oxidized low-density
lipoprotein (ox-LDL) stands as a critical event in the advancement of atherosclerosis (AS) …

Background Sepsis can lead to myocardial depression, playing a significant role in sepsis
pathophysiology, clinical care, and outcome. To gain more insight into the pathophysiology …

Hypertrophic cardiomyopathy (HCM) is a common heart disease in humans and cats,
nonetheless, the disease pathogenesis is still poorly understood. MicroRNAs are suspected …

Background Hypertrophic cardiomyopathy (HCM) is a widespread hereditary cardiac
pathology characterized by thickened heart walls and rearrangement of cardiomyocytes …

Hypertrophic cardiomyopathy (HCM) is a hereditary heart disease caused by mutations in
the sarcomere genes, which is accompanied by myocardial fibrosis leading to progressive …

Background: Recently, we demonstrated transcriptional downregulation of hypertrophy
pathways in myectomy tissue derived from patients with obstructive hypertrophic …

This study explores microRNAs (miRNAs) as biomarkers for hypertrophic cardiomyopathy
(HCM), an inherited cardiac disease with clinical diversity and sudden death risk. Using …

Background: Marfan Syndrome (MFS) is a monogenic multisystem disorder resulting from
mutations in fibrillin-1, resulting in thoracic aortic aneurysm. Currently, effective treatments …

Гипертрофическая кардиомиопатия (ГКМП)-наследственная патология сердца,
обусловленная мутациями в генах саркомеров, которая сопровождается фиброзом …